Why Office Properties Income Trust Stock Is Tanking Today The Motley Fool

The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, https://1investing.in/ and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations.

In predicting a stock’s future price performance, it’s crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company’s growth prospects. For the current fiscal year, the consensus earnings estimate of $0.23 points to a change of +243.8% from the prior year. Over the last 30 days, this estimate has changed -20.7%. 1 Wall Street analysts have issued 12 month price targets for Diversified Healthcare Trust’s stock. Their DHC share price forecasts range from $4.50 to $4.50.

Data are provided ‘as is’ for informational purposes only and are not intended for trading purposes. Data may be intentionally delayed pursuant to supplier requirements. DHC’s beta can be found in Trading Information at the top of this page. A stock’s beta measures how closely tied its price movements have been to the performance of the overall market. Recent stocks from this report have soared up to +178.7% in 3 months – this month’s picks could be even better. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.

Earnings

Style is calculated by combining value and growth scores, which are first individually calculated. The Barchart Technical Opinion widget shows you today’s overally Barchart Opinion with general information on how to interpret the short and longer term signals. Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. After each calculation the program assigns a Buy, Sell, or Hold value with the study, depending on where the price lies in reference to the common interpretation of the study. For example, a price above its moving average is generally considered an upward trend or a buy.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%. An industry with a larger percentage of Zacks Rank #1’s and #2’s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4’s and #5’s. Plus, DHC info will be updated daily in your Zacks.com Portfolio Tracker – also free. Upgrade to MarketBeat All Access to add more stocks to your watchlist.

Earnings Transcripts

The documents provided in this archived section are provided for historical purposes only. Diversified Healthcare Trust does not undertake any obligation to update any information contained in these documents. For current information about the company, please refer to our most recent public SEC Filings. The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction. However, some other stocks were exhibiting unusual options activity.

Compare

DHC’s historical performance

against its industry peers and the overall market. Matthew DiLallo has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. It needs to actively manage lease expirations in a very tough office market so it can continue to generate cash flow to deleverage its balance sheet and fund redevelopment projects. Office Properties Trust’s decision to terminate its merger with Diversified Healthcare was the right move. The deal would have merged two troubled entities, which would have made the combined company even weaker.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors’ interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

Investors Seeking Yield Might Want to Try a ‘Small Dogs’ Strategy. The Caveat: Volatility.

Provides a general description of the business conducted by this company. DHC earnings call for the period ending December 31, 2020. DHC earnings call for the period ending September 30, 2021.

Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Diversified Healthcare is rated Zacks Rank #4 (Sell). Information about DHC’s trustees and executive officers is also included in the proxy statement for DHC’s 2023 annual meeting of shareholders, which was filed with the SEC on April 20, 2023. Information about OPI’s trustees and executive officers is included in the proxy statement for OPI’s 2023 annual meeting of shareholders, which was filed with the SEC on April 6, 2023.

We’d like to share more about how we work and what drives our day-to-day business. Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, inverted head and shoulders from our research and data to our policies on content and your personal data. Our Quantitative Research team models direct competitors or comparable companies

from a bottom-up perspective to find companies describing their business in a

similar fashion.

Because of that, it’s still not worth buying despite the merger termination, even though it offers a hefty dividend yield despite cutting its payout earlier this year. Office Properties Trust and Diversified Healthcare Trust announced plans to merge in an all-stock deal in April. The transaction would have created a diversified REIT with office and healthcare properties.

On average, they predict the company’s share price to reach $4.50 in the next year. This suggests a possible upside of 93.1% from the stock’s current price. View analysts price targets for DHC or view top-rated stocks among Wall Street analysts.

Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares

Over the last four quarters, the company surpassed EPS estimates just once. The company could not beat consensus revenue estimates in any of the last four quarters. Even though a company’s earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues.

EPS of -$0.30 for the same period compares with -$0.04 a year ago. For Diversified Healthcare, the consensus sales estimate for the current quarter of $356.42 million indicates a year-over-year change of +10.4%. For the current and next fiscal years, $1.41 billion and $1.52 billion estimates indicate +10.2% and +7.2% changes, respectively. Diversified Healthcare is expected to post earnings of $0.08 per share for the current quarter, representing a year-over-year change of +233.3%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged. Style is an investment factor that has a meaningful impact on investment risk and returns.

Diversified Healthcare Trust (DHC) Is a Trending Stock: Facts to Know Before Betting on It

For current information about DHC, please refer to DHC’s most recent public SEC Filings. You should not place undue reliance upon any forward-looking statements. Except as required by law, DHC does not intend to update or change any forward-looking statements as a result of new information, future events or otherwise.

ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Diversified Healthcare (DHC Quick QuoteDHC – Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. These significant issues caused intense opposition to the merger. A proxy advisory firm called the industry logic behind the deal “deeply flawed,” leading it to recommend that investors vote against the transaction. Because of that, the two companies likely wouldn’t get enough shareholder support to approve the deal.

That’s because we believe the present value of its future stream of earnings is what determines the fair value for its stock. Diversified Healthcare (DHC) is one of the stocks most watched by Zacks.com visitors lately. The scores are based on the trading styles of Value, Growth, and Momentum. There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score. According to one analyst, the rating for DHC stock is “Strong Buy” and the 12-month stock price forecast is $4.5. © 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

• Compare

  DHC’s historical performance

  against its industry peers and the overall market.

• ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
• For example, a price above its moving average is generally considered an upward trend or a buy.
• Compared to the Zacks Consensus Estimate of $353.15 million, the reported revenues represent a surprise of -1.96%.
• Information about OPI’s trustees and executive officers is included in the proxy statement for OPI’s 2023 annual meeting of shareholders, which was filed with the SEC on April 6, 2023.

It’s almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company’s potential revenue growth is crucial. Here at Zacks, we prioritize appraising the change in the projection of a company’s future earnings over anything else.